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Summary
Objective: The higher incidence of osteoarthritis in females suggests that there may be intrinsic sex-speciﬁc differences in human articular
chondrocytes. 17b-Estradiol (E2) regulates rat growth plate chondrocytes through traditional nuclear receptor mechanisms, but only female
cells exhibit rapid membrane-associated effects mediated through protein kinase C (PKC) alpha. Here we demonstrate sexual dimorphism in
the physiological response of human articular chondrocytes to E2.
Methods: Articular chondrocytes were obtained at the time of autopsy from three male and three female donors between 16 and 39 years of
age. Second passage cultures were treated with E2 for 24 h to assess the effects of the hormone on [
3H]-thymidine incorporation, [35S]-sulfate
incorporation, and alkaline phosphatase speciﬁc activity. In addition, the chondrocytes were treated for 3, 9, 90 or 270 min and PKC speciﬁc
activity was determined.
Results: All chondrocytes were positive for aggrecan and estrogen receptor alpha mRNAs but were negative for type II collagen mRNA. Only
cells from female donors responded to E2. DNA synthesis, sulfate incorporation and alkaline phosphatase activity were increased. E2 caused
a rapid increase in PKC activity in the female cells within 9 min that was maximal at 90 min. Treatment with the PKC inhibitor chelerythrine
blocked these effects.
Conclusions: These results provide the ﬁrst deﬁnitive evidence that normal human cells exhibit an intrinsic sex-speciﬁc response to E2 and
suggest that sexual dimorphism may be an important variable in assessing the pathways that modulate cell behavior.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Epidemiological studies show sex-speciﬁc differences in
both prevalence and severity of osteoarthritis1e4. Men
exhibit higher prevalence of osteoarthritis before age 50,
while women have a higher prevalence after age 50. In
addition, postmenopausal women are more likely to have
a general form of the disease that affects multiple joints with
greater severity. This epidemiologic and pathologic gap
between the sexes continues to increase with advancing
age. Attempts to correlate biomechanical differences
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2004.33between males and females with the incidence and
prevalence of osteoarthritis have failed to identify a causa-
tive factor, suggesting that there may be innate differences
at the cellular level that contribute to disease severity.
One possibility is that sensitivity to estrogen plays a role.
The presence of estrogen receptors (ER) alpha and beta in
chondrocytes supports clinical observations that articular
cartilage is an estrogen-sensitive tissue5e8. The parameters
by which estrogen modulates chondrocyte behavior are not
well understood, however. Human clinical studies using
hormone replacement therapy have failed to show a con-
sistent correlation between serum estradiol levels and
development or progression of osteoarthritis9e11. Animal
models have likewise shown differing results depending on
the model12e16.
Studies examining effects of 17b-estradiol (E2) on growth
plates of mice and rats in organ culture indicate that
responses to the hormone differ in a sex-dependent
manner17, suggesting that the sexual dimorphism is at the
cellular level. ERa and ERb are present in rat growth plate
chondrocytes18, but female cells possess more high afﬁnity0
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differences in physiological responses ofmale and female rat
growth plate chondrocytes to E2
20. Female cells demon-
strated decreased proliferation and increased alkaline
phosphatase activity, indicating that E2 promotes differenti-
ation. E2 also affected extracellular matrix production,
resulting in increased synthesis of both collagen and
proteoglycan. These effects were not seen in male cells or
with 17a-estradiol.
Stereospeciﬁcity of the response to estrogen suggests
a receptor-mediated mechanism. E2-treatment increases
membrane ﬂuidity and phospholipid metabolism in female
cells21, and also results in rapid elevation of protein kinase
C (PKC) activity22. The increase in PKC is mediated
through G-proteins and phospholipase C23. A similar
increase in PKC activity was observed when E2 was
conjugated with bovine serum albumin to prevent diffusion
through the plasma membrane24, thereby inhibiting in-
teraction with cytosolic ERs. Whereas tamoxifen blocks E2
activation of PKC in growth plate chondrocytes, neither the
ER agonist diethylstilbestrol nor the ER antagonist ICI
182780 has an effect18, suggesting that E2 regulates
chondrocytes through mechanisms other than those tradi-
tionally associated with nuclear receptors. E2 also activates
PKC in human colon cancer cells only from females25, and
activates PKC in female rat distal colon by an ICI 182780-
insensitive mechanism26.
Our goal was to determine if sexual dimorphism in
response to estrogen is a feature of human articular
chondrocytes. Cells from multiple donors were examined
to verify that differences in response were due to genetic
sex and not normal human variation. We ﬁrst characterized
the human articular chondrocytes to ensure they were
phenotypically chondrocytes, and then examined their
response to E2 by measuring changes in proliferation,
differentiation and matrix deposition. Finally, we investi-
gated the potential role of PKC signaling in E2 stimulation of
human articular chondrocytes.
Materials and methods
HUMAN ARTICULAR CHONDROCYTE ISOLATION
AND CELL CULTURE
Articular cartilage was isolated from the femoral condyles
and tibial plateaus of human donors made available due to
autopsy. Donors had no known history of joint disease and
histological analysis was performed at the time of isolation to
conﬁrm the absence of any pathologies. The articular
cartilage was cut into small pieces and washed twice for
20 min with Hank’s balanced salt solution (HBSS) containing
1% penicillin and streptomycin. The washed cartilage was
digested for 1 h with 0.25% trypsin-1 mM ethylene diamine
tetraacetic acid (EDTA), followed by treatment with 0.2%
collagenase for 3 h. All enzymes were prepared in HBSS.
The digested suspension was passed though a 40 mmmesh
sieve and centrifuged at 2000 rpm for 10 min. The
supernatant was removed and the chondrocytes were
resuspended in full media containing 88% Dulbecco’s
modiﬁed Eagle’s medium (DMEM), 10% fetal bovine serum
(FBS), 1% penicillin/streptomycin, and 1% L-ascorbic acid27.
Isolated primary chondrocytes were plated on T75
ﬂasks, grown to conﬂuence, and harvested using 0.25%
trypsin-1 mM EDTA. The cell suspension was centrifuged at
2000 rpm for 10 min, the supernatant removed, and the
cells resuspended in cold DMEM, 20% FBS, 1% penicillin/streptomycin, and 5% dimethyl sulfoxide. The chondrocytes
were then frozen at 80(C and shipped overnight from La
Jolla, CA to Atlanta, GA. The chondrocytes were thawed,
centrifuged, resuspended in full media and plated on T75
ﬂasks. These cultures were grown to conﬂuence and
passaged one time as above. Thus second passage
human chondrocytes were used for all experiments.
Conﬂuent second passage cultures were also used to
assess expression of chondrocyte phenotypic markers. It
was necessary to expand the cells in culture in order to
obtain sufﬁcient numbers for each set of assays.
EXPRESSION OF AGGRECAN AND COLLAGEN
Articular chondrocytes dedifferentiate when expanded in
monolayer cell culture28,29. Therefore, reverse transcription
polymerase chain reaction (RT-PCR) was used to assess
the phenotype of the second passage human chondrocytes
by measuring the mRNA expression of aggrecan, collagen I,
collagen II, and collagenX. Total RNAwas extracted from the
chondrocyte cultures with Trizol reagent. Lipophilic contam-
inants were removed by adding chloroform and centrifuging
for 25 min at 4700 rpm. The aqueous phase was then
washed with isopropyl alcohol to precipitate the RNA, and
centrifuged for 20 min at 4700 rpm to form a pellet. The pellet
was washed with cold 70% ethanol and centrifuged for
15 min at 4700 rpm. The supernatant was removed and the
pellet allowed to air dry. The RNA was then dissolved in
diethyl pyrocarbonate (DEPC) treated water and the purity
and quantity was determined by UV spectrophotometry.
The total RNA sample from each donor was reverse
transcribed using the First-strand cDNA Synthesis Kit
(Amersham Biosciences, Piscataway, NJ) and the speciﬁc
anti-sense primer for each mRNA of interest. The cDNA was
ampliﬁed using the Fisher PCR kit (Fisher Scientiﬁc
International, Hampton, NH) and the speciﬁc sense and
anti-sense primers. PCR conditions for each cycle included
a 30 s denaturation at 94(C, a 60 s annealing at 50e65(C
depending on the primer used, and a 30 s extension at
72(C. The PCR-ampliﬁed products were run on 5% poly-
acrylamide gels using a buffer consisting of 0.9 M Trizma
base (tris[hydroxymethyl]aminomethane), 0.9 M boric acid,
and 20 mM EDTA. Primary human ﬁbroblast RNA was used
as the positive control for collagen I, and RNA extracted from
rat growth plate cartilage was used as the positive control for
collagen X. The negative control for the extracellular matrix
components was human lymphocyte RNA.
The primer sequences and annealing temperatures for
each marker were as follows. Aggrecan sense primer was
5#-TGA GGA GGG CTG GAA CAA GTA CC-3# and anti-
sense primer was 5#-GGA GGT GGT AAT TGC AGG GAA
CA-3# with an annealing temperature of 65(C. Collagen I
sense primer was 5#-GTC AGG CTG GTG TGA TGG GA-3#
and anti-sense primer was 5#-AACCTCTCTCGCCTCTTG
CT-3# with an annealing temperature of 59.8(C. Collagen II
sense primer was 5#-CTGCTCGTCGCCGCTGTCCTT-3#
and anti-sense primer was 5#-AAG GGT CCC AGG TTC
TCC ATC-3# with an annealing temperature of 56.4(C.
Collagen X sense primer was 5#-AGT CCT GGA CTC CAA
CGA-3# and anti-sense primer was 5#-TGG AAG ACC CCT
CTC AC-3# with an annealing temperature of 54.6(C.
ER EXPRESSION
RT-PCR for ERa was performed as above except RNA
from human ovarian tissue was used as a positive control.
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TGT-3# and anti-sense primer was 5#-TCA AAG ATC TCC
ACC ATG CC-3# with an annealing temperature of 57.0(C.
EFFECT OF E2 ON PROLIFERATION
DNA synthesis was estimated by measuring [3H]-thymi-
dine incorporation30. Second passage chondrocytes were
grown to subconﬂuence in 96-well plates, and made
quiescent for 48 h by incubating with media containing 1%
FBS. The cells were then treated with 1011e107 M E2 in
1% FBS media for 24 h. Four hours prior to harvest,
0.05 mCi of [3H]-thymidine was added to each well, giving
a ﬁnal concentration of 0.25 mCi/ml. At harvest, the cells
were washed twice with 200 ml phosphate buffered saline
(PBS), and then ﬁxed by washing three times in 5%
trichloracetic acid. The samples were then allowed to air dry
and 100 ml 1% sodium dodecyl sulfate was added to each
well. The samples were incubated overnight at 4(C,
scraped, transferred to scintillation vials ﬁlled with 10 ml of
Ready-gel (Beckman Coulter, Fullerton, CA) and counted
for 1 min. Each sample was normalized by the total protein
content per well, as the assay precludes cell counting or
measurement of DNA content.
ALKALINE PHOSPHATASE SPECIFIC ACTIVITY
Cells from each donor were grown to conﬂuence in 24-
well plates and treated with 1011e107 M E2 24 h prior to
harvest. At harvest, cells were washed twice with 500 ml
PBS. An additional 500 ml of PBS was added, and the cell
layer was scraped and transferred to 12! 75 mm test
tubes. Another 500 ml of PBS was added to the test tubes,
and samples were centrifuged for 20 min at 3200 rpm. The
supernatant was decanted, another 500 ml of PBS added,
and centrifugation was repeated. The supernatant was
decanted again, and the pellet was suspended in 500 ml of
a 5% Triton X solution. Samples were subjected to three
cycles of freeze/thaw treatment in a methanol/dry ice bath
to break up the cell layer pellet and 50 ml of each sample
was aliquoted into a 96-well plate in duplicate.
A buffer solution consisting of 2-amino-2-methyl-1-prop-
anol, p-nitrophenyl phosphate, and MgCl2 was mixed in
a 1:1:1 (v/v/v) ratio. Fifty microliters of the buffer solution
was added to each well in the 96-well sample plates, and
the plates were incubated at 37(C. Samples were in-
cubated until they were a pale yellow color within the range
of the standard curve but not longer than 3 h31. After
removing the plates, 100 ml of NaOH was added to stop the
reaction, and the plates were read in a Bio-Rad microplate
reader (Bio-Rad Laboratories, Hercules, CA) at 405 nm.
Each sample was normalized by the total protein content
per well to determine speciﬁc activity.
PROTEOGLYCAN PRODUCTION
[35S]-Sulfate incorporation was used to measure pro-
teoglycan production32 in response to E2. Chondrocytes
were grown to conﬂuence in 24-well plates and treated with
1011e107 M E2 for 24 h. Four hours prior to harvest, 5 mCi
of [35S]-sulfate was added to each sample, giving a ﬁnal
concentration of 9 mCi/ml. At harvest, cells were washed
once with PBS, 250 ml of 0.25 M NaOH was added, and the
cells were scraped and transferred to 12! 75 mm tubes.
Additional NaOH was added and the cell scraping repeated.
Samples were vortexed and 50 ml removed for proteindetermination. Two hundred and ﬁfty microliters of 0.15 M
NaCl was added, and the samples were put in approximately
5-cm pieces of prepared 0.25 mm thick, 12e14 kD molec-
ular weight cut-off, dialysis tubing. The tubing was prepared
in a solution of 100 mM NaHCO3 and 10 mM Na2EDTA. It
was incubated at 60(C for 2 h in a shaking water bath. The
incubation was repeated for another 2 h with warm, fresh
solution. The solution was replaced with 2 L of warm,
ultrapure water, and incubated for 1 h. Water replacement
and incubation were repeated until the water became clear.
The tubing and water were cooled to 4(C and the water was
replaced with 10% methanol. Tubing with the samples was
placed in a 4 L beaker with dialysis solution (0.15 M NaCl,
20 mM Na2SO4, 20 mM Na2PO4, pH 7.4) and incubated at
4(C for 24 h. The solution was replaced every 8 h until the
radioactivity was similar to baseline. Sample tubes were
transferred into scintillation vials ﬁlled with 10 ml of Ready-
gel and counted for 1 min. Each sample was normalized by
the total protein content per well.
PKC ACTIVITY
Chondrocytes from each donor were grown to conﬂuence
in 24-well plates. Cells were treated with 1011e107M E2
for 3, 9, 90, and 270 min. At harvest, the cells were washed
twice with 500 ml PBS, and 300 ml of RIPA buffer was added
to lyse the cells. The PKC activity of each sample was
measured using the Biotrak Protein Kinase C enzyme Assay
Kit and procedure from Amersham Biosciences. The system
is based upon the PKC catalyzed transfer of [32P]-PO4 from
[32P]-g-ATP to a peptide speciﬁc for PKC. The reaction
mixture consisted of 3 mM calcium acetate, 0.075 mg/ml
La-phosphatidyl-L-serine, 6 mg/ml phorbol 12-myristate
13-acetate, 150 mM PKC speciﬁc peptide, and 7.5 mM
dithiothreitol in a 50 mM Tris/HCl buffer containing 0.05%
(w/v) azide at pH 7.5. Twenty-ﬁve microliters of the mixture
was added to 25 ml of each sample. g-ATP phosphorous-32
was mixed with a 1.2 mM ATP, 30 mM Hepes, 72 mM
magnesium chloride solution at pH 7.4 and a total count of
450,000G 20,000 cpm per 5 ml was obtained. Five micro-
liters of radioactive ATP buffer was added to each sample.
The samples were centrifuged and incubated at 37(C for
15 min. After incubation, 10 ml of the stop reagent containing
300 mM ortho-phosphoric acid and carmosine red was
added and the samples were centrifuged again. The
samples were mixed, and 35 ml was transferred to the
peptide binding papers provided in the kit. The papers were
dried for 5 min and then washed twice in 75 mM ortho-
phosphoric acid solution with agitation for 5 min. The paper
disks were transferred into scintillation vials ﬁlled with 10 ml
of Ready-gel and counted for 1 min each. The total pmols
phosphate (P) transferred per minute were calculated as
follows: PZ (T! 1000)/(I!R), where I is the incubation
time. The speciﬁc activity (R) of 1.2 mMMg [32P]ATP is equal
to the total count (450,000G 20,000 cpm) per 5 ml divided by
the number of moles of ATP (6! 109) per 5 ml. The total
phosphate (T ) transferred to peptides and endogenous
proteins is equal to the sample cpm minus the blank cpm.
The blank cpm was measured using both cell lysate free
reactions with reaction buffer to determine the background,
and with cell lysate containing samples without reaction
buffer to measure phosphorylation of endogenous proteins.
Both blanks were signiﬁcantly lower than the samples, but
were equal to each other, indicating that there was minimal
phosphorylation of endogenous proteins. Each sample was
then normalized by the total protein content per well.
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All samples were normalized by total protein content
using the Pierce Macro BCA Protein Assay Reagent kit
(Pierce Biotechnology, Rockford, IL). Reagents A and B
were mixed in a 50:1 ratio to make the working reagent.
Twenty-ﬁve microliters of each sample was aliquoted in
duplicate to 96-well plates, and 200 ml of the working
reagent was added to the sample plates. They were
incubated at 37(C for 30 min and read in the Bio-Rad
microplate reader at 570 nm.
PKC INHIBITION
To test whether the effects of E2 on female human
chondrocytes were mediated by PKC, conﬂuent cultures
were treated with 108 M E2 in the presence and absence
of 0.1, 1, or 10 mM chelerythrine. Chelerythrine has been
shown to speciﬁcally inhibit PKC at concentrations less than
10 mM in several cell systems33e35. We previously showed
that the effects of E2 on rat growth plate chondrocytes are
blocked by chelerythrine as well as by other PKC inhibitors
including staurosporine and H-736. Following treatment,
[35S]-sulfate incorporation was measured as described
above.
Results
Expansion of human articular chondrocytes for two
passages in monolayer culture resulted in partial loss of
phenotypic expression. The chondrocytes retained their
ability to express aggrecan core protein mRNA (Fig. 1), but
lost expression of collagen type II mRNA (data not shown).
The cells showed an increase in collagen type I mRNA
expression (Fig. 1), but did not show any expression of
collagen type X (data not shown). Despite loss of collagen
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Fig. 1. Characterization of second passage human articular
chondrocytes using RT-PCR. The phenotype of the human
chondrocytes was assessed by measuring the mRNA expression
of aggrecan, collagen I, collagen II, collagen X and ERa. Both
female and male cells showed expression of mRNA for aggrecan,
collagen I, and ERa. There was no detectable expression of
collagen II or collagen X. The results indicate that second passage
human articular chondrocytes are partially dedifferentiated towards
a ﬁbroblastic phenotype. However, the dedifferentiation is not sex-
speciﬁc and the expression of ERa is retained in both male and
female cells as well.type II expression, second passage cells were chosen in
order to use the same six donors for all experiments,
thereby reducing potential variability between donors. The
mRNA expression for the above matrix components was
not dependent on donor sex indicating that loss of collagen
type II expression was not regulated in a sex-speciﬁc
manner.
Human articular chondrocytes exhibited clear sexual
dimorphism in their physiological response to E2.
Chondrocytes from all three female donors showed dose-
dependent increases in [3H]-thymidine incorporation,
signiﬁcant at 109 M E2 [Fig. 2(A)]. DNA synthesis in male
cells did not show any signiﬁcant response to estrogen at
the concentrations used. E2 also regulated chondrocyte
differentiation in a sex-speciﬁc manner. Cells from female
donors showed dose-dependent increases in alkaline
phosphatase activity, signiﬁcant at 1010 M [Fig. 2(B)].
Levels of alkaline phosphatase activity in male chondro-
cytes were unchanged by estrogen treatment. Similarly, E2
treatment caused sex-speciﬁc and dose-dependent in-
creases in [35S]-sulfate incorporation [Fig. 2(C)], which
were found in chondrocytes from all three female donors at
1010 M. E2 did not affect this parameter in chondrocytes
from male donors.
Both male and female chondrocytes expressed mRNA
for ERa and when normalized to glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) expression (Fig. 1), there
were no apparent differences in mRNA levels due to donor
sex. The presence of ERs in both sexes suggests the sex-
speciﬁc response to E2 acts through a different mechanism.
PKC-dependent signaling is clearly involved. As noted
previously for female rat growth plate cartilage cells22 and
human colon cancer cells25, only female human articular
chondrocytes showed a rapid dose-dependent increase in
PKC activity in response to estrogen (Fig. 3). The effect was
signiﬁcant at 9 min, reached a maximum at 90 min, and was
found at concentrations as low as 1010 M E2 for individual
patients and at 109 M E2 when the results for all three
patients were combined. In contrast, chondrocytes from
male donors did not exhibit a signiﬁcant response to E2 at
any of the concentrations or time points tested.
Treatment of the cells with chelerythrine blocked the
stimulatory effect of the hormone on proteoglycan synthesis
(Fig. 4). The effects of chelerythrine were dose-dependent.
At the lowest dose (0.1 mM), the inhibitor reduced [35S]-
sulfate incorporation in E2-treated cultures to control levels,
completely abrogating the effect of the hormone. Cheler-
ythrine also appeared to decrease [35S]-sulfate incorpora-
tion in untreated cultures but this effect was not signiﬁcant.
Discussion
It has been difﬁcult to study the effects of hormones on
articular chondrocytes in vitro because they undergo a pro-
cess known as dedifferentiation when cultured on two-
dimensional surfaces. The lack of a three-dimensional
matrix causes the down-regulation of cartilage speciﬁc
processes. Chondrocyte dedifferentiation was ﬁrst de-
scribed in embryonic chick chondrocytes as changes in
collagen synthesis37, and was later conﬁrmed in rabbit
articular chondrocytes38. Current biochemical analysis has
shown that adult rabbit articular chondrocytes have com-
plete loss of collagen type II mRNA expression and protein
synthesis after two passages when seeded at low densities,
deﬁned as 104 cells/cm2 (Ref.39). Experiments on human
fetal articular chondrocytes have also shown decreased
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synthesis of human articular chondrocytes. (A) [3H]-Thymidine
incorporation was used to measure DNA synthesis. Female
chondrocytes showed a signiﬁcant increase in proliferation
compared to control at 109e107 M E2. Male chondrocytes did
not show a response to E2. (B) Alkaline phosphatase activity was
used to indicate changes in chondrocyte differentiation. Female
chondrocytes showed a signiﬁcant increase in alkaline phospha-
tase activity compared to control at 1010e107 M E2. Male
chondrocytes did not show a response. (C) Matrix synthesis was
quantiﬁed using [35S]-SO4 incorporation to measure proteoglycan
production. Female chondrocytes showed a signiﬁcant response
compared to control at 1010e107 M E2. Male chondrocytes once
again did not show a response to E2. Values are the meanG S.E.M.
of six cultures from one of two experiments, both showing
comparable results. *P! 0.05, treatment vs control.collagen type II mRNA expression in primary cultures after
7e10 days of low density culture40. Our adult human
articular chondrocyte model also had undetectable levels
of collagen type II mRNA after two passages, but continued
to strongly express aggrecan, a chondrocyte-speciﬁc
proteoglycan core protein. We were unable to verify that
Fig. 3. Effect of E2 on PKC speciﬁc activity in human articular
chondrocytes. (A) Female chondrocytes showed a signiﬁcant
response compared to control at 109e107 M E2 while male cells
did not show a response. (B) The effect of E2 on PKC activity is time
dependent for female chondrocytes with a signiﬁcant response at
9 min and a maximal response at 90 min. (C) Male chondrocytes
did not show a response at any of the time points tested. Values are
the meanG S.E.M. of six cultures from one of two experiments, both
showing comparable results. *P! 0.05, treatment vs control.
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we used banked chondrocytes. In addition, the ﬁrst passage
cell stocks needed to be subpassaged at least once to
obtain the number of cells needed for the experiments. This
allowed the same six donors to be used for all the
experiments, thereby decreasing genetic variability. The
use of primary cells is preferred, but it is not practical in an
adult human articular chondrocyte model.
It is possible that the sex-speciﬁc differences we see are
due to the dedifferentiation effects, but it is unlikely. The
dedifferentiation process does not appear to be sex-speciﬁc
using the standard chondrocytic markers. However, if
monolayer cell culture does indeed result in sex-speciﬁc
changes in the biochemistry of cells then these results are
even more relevant to the biological research community at
large and should be further investigated.
Our results suggest that the sex-speciﬁc effects of E2 on
proteoglycan production are mediated by PKC. Inhibition of
PKC with chelerythrine at concentrations as low as 0.1 mM
completely blocked the stimulatory effects of the hormone.
We previously examined the effect of E2 on rat growth plate
chondrocytes with and without chelerythrine and compared
immunoprecipitation kinase assays using isoform speciﬁc
antibodies22. Chelerythrine was shown to speciﬁcally inhibit
PKCa, which was the isoform shown to be upregulated by
E2 in rat growth plate chondrocytes. We also compared the
effects of three PKC-speciﬁc inhibitors (chelerythrine,
staurosporine, and H-7) on TGF-b1 stimulated PKC activity
in the same rat growth plate model and found similar results
with all three inhibitors36. Chelerythrine has also been used
as a PKC-speciﬁc inhibitor in other musculoskeletal cell
models41e43. However, chelerythrine has been shown to
affect other signaling pathways in non-musculoskeletal
cells44,45 and has variable effects on PKC in brain
tissue33,46. Recently, investigators have reported that they
failed to observe PKC inhibition when using chelerythr-
ine44,45, but the assays used in these studies were different
from the ones reported here and the tissues involved were
non-skeletal. While it is likely that E2 exerts its effects via
Fig. 4. Effect of chelerythrine, a general PKC inhibitor, on E2
stimulated matrix synthesis. Conﬂuent second passage chondro-
cytes were treated for 24 h with control media or 108 M E2
containing 0.1, 1, or 10 mM chelerythrine. The increase in pro-
teoglycan production associated with E2 treatment was completely
blocked by the addition of chelerythrine. Values are the meanG
S.E.M. of six cultures from one of two experiments, both showing
comparable results. #P! 0.05, treatment vs control. *P! 0.05,
inhibitor vs treatment.multiple pathways, the results presented here implicate
PKC in the mechanism.
The fact that increased PKC activity occurs within
minutes suggests that E2 may activate a non-genomic
signaling pathway through a membrane-associated
receptor. Recent studies have identiﬁed both ERa and
ERb in the plasma membrane of estrogen-responsive
cells8,47, as well as the presence of truncated forms of
these receptors48. It is not yet known if one or more of these
entities are responsible for PKC activation and trans-
location. It is possible that male chondrocytes do not
express some component of this membrane receptor and
therefore are not affected by E2. It is also important to note
that male chondrocytes are deﬁcient in some part of the
genomic estrogen signaling pathway since they did not
show any response to E2 after 24 h of treatment even
though they express ER. Not all responses to E2 are sex-
speciﬁc, however. Both male and female osteoblasts
respond to E2 with increased src-dependent MAPK
49.
In vivo, both male and female chondrocytes produce
estrogen via aromatization of testosterone50, but male cells
also convert testosterone to 5-hydroxytestosterone (DHT)
via 5-alpha reductase51. Some effects of testosterone are
also sex-speciﬁc and are mediated by DHT52. It is unknown
what additional effects estrogen metabolites may have on
male cells.
Under normal physiological conditions, female cells
would be exposed to higher levels of estrogen, both
systemically as well as locally. Studies using growth plate
chondrocytes as the model indicate that local levels of
estrogen can be as high as 108 M53, which is the
concentration at which the membrane-associated PKC-
dependent signaling is maximally stimulated. These obser-
vations support the hypothesis that the female response to
estrogen involves membrane-associated signaling via PKC
in addition to traditional nuclear receptor-mediated mecha-
nisms, as noted by others for female colon cancer cells25
and female rat distal colon26. The present study is the ﬁrst
to show a clear sex-speciﬁc effect of the hormone in
a normal human cell model.
Although there are many similarities between the re-
sponse of rat growth plate chondrocytes and human articular
chondrocytes to E2, there are also differences. Most notably,
E2 inhibits DNA synthesis in rat growth plate chondro-
cytes23, whereas it stimulates [3H]-thymidine incorporation
in human articular chondrocytes. In both instances the
effects of the hormone are sex-speciﬁc. Our results indicate
that there are fundamental differences between human male
and female chondrocytes that modulate their response to
normal physiological regulators. This sexual dimorphism
has important implications for applications that require
functional adaptation of donor cells of one sex in hosts of
another sex. Certainly sex is a variable that must be
considered in interpreting results describing cell behavior
in culture and in vivo. The greater incidence in females of
osteoarthritis and inﬂammatory diseases affecting cartila-
ge1e4 support the hypothesis that development of pathology
may be due in part to intrinsic sex-speciﬁc differences in
female and male chondrocytes.
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